A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

By Pam Belluck from NYT Health https://ift.tt/nsUP6Y7
Clinical Trials, Drugs (Pharmaceuticals), Amyotrophic Lateral Sclerosis, Corporations, Suits and Litigation (Civil), Brain, your-feed-science, your-feed-healthcare